CASP9 and lip and oral cavity carcinoma: Notably, X-ray/SK2 treatment exhibited higher activated caspase 9 (+) (%) in oral cancer cells than in normal cells, i.e., 60.0%, 95.7% vs. 45.0% for Ca9-22, CAL 27 vs. S-G, respectively.